Alpha DNA Investment Management LLC Has $2.16 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Alpha DNA Investment Management LLC reduced its holdings in Colgate-Palmolive (NYSE:CL) by 13.2% in the 3rd quarter, HoldingsChannel reports. The fund owned 20,784 shares of the company’s stock after selling 3,155 shares during the period. Colgate-Palmolive comprises approximately 0.8% of Alpha DNA Investment Management LLC’s holdings, making the stock its 18th biggest position. Alpha DNA Investment Management LLC’s holdings in Colgate-Palmolive were worth $2,158,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Advisors Asset Management Inc. grew its holdings in Colgate-Palmolive by 263.2% during the 1st quarter. Advisors Asset Management Inc. now owns 27,126 shares of the company’s stock worth $2,443,000 after acquiring an additional 19,657 shares during the period. 1832 Asset Management L.P. grew its position in shares of Colgate-Palmolive by 4,847.3% during the 1st quarter. 1832 Asset Management L.P. now owns 9,301 shares of the company’s stock worth $838,000 after buying an additional 9,113 shares during the period. SVB Wealth LLC increased its stake in shares of Colgate-Palmolive by 2.7% in the 1st quarter. SVB Wealth LLC now owns 34,883 shares of the company’s stock valued at $3,141,000 after acquiring an additional 920 shares in the last quarter. Industrial Alliance Investment Management Inc. lifted its position in shares of Colgate-Palmolive by 4.4% during the 1st quarter. Industrial Alliance Investment Management Inc. now owns 4,185 shares of the company’s stock valued at $377,000 after acquiring an additional 176 shares during the period. Finally, B. Riley Wealth Advisors Inc. grew its holdings in Colgate-Palmolive by 0.8% in the first quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock worth $1,498,000 after purchasing an additional 138 shares during the period. Institutional investors own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price objective for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. Sanford C. Bernstein upped their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. Wells Fargo & Company cut their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. Barclays boosted their price target on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research note on Monday, July 29th. Finally, Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Trading Up 0.7 %

NYSE CL opened at $94.92 on Friday. Colgate-Palmolive has a one year low of $75.50 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business’s fifty day moving average is $98.10 and its 200-day moving average is $98.54. The stock has a market capitalization of $77.55 billion, a price-to-earnings ratio of 27.20, a PEG ratio of 3.36 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $0.50 per share. The ex-dividend date was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.11%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.